WebJan 31, 2024 · Press Releases All; 2024; 2024; 2024; 2024; 2024; 2024; 2016; March 31, 2024 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) ... Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non … WebSep 29, 2024 · Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43 M337V disease model and early access to …
bit.bio raises $103 million in first close of series b financing
WebJun 16, 2024 · Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells for the wellbeing of humanity, has announced the close of a $41.5 million Series A investment, bringing the company’s total funding to $50 million. In a strong statement of support for the company’s goal to transition biology into ... WebFeb 17, 2024 · Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking ... how badly was ann heche burned
bit.bio Expands Its Portfolio With Three New Human Cell Products …
WebFeb 16, 2024 · - PDUFA goal date is August 19, 2024 - PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 16, 2024-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that the U.S. Food and Drug Administration (FDA) has … WebMar 13, 2024 · Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D). Paris and Red Bank, N.J. March 13, 2024 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated … WebNov 17, 2024 · Kathryn Corzo, COO at bit.bio said: “My passion and life work is to deliver transformative therapies for patients in need. Cell therapies hold significant promise yet R&D is extremely expensive and complex. bit.bio has a unique platform technology to address many challenges of cell therapy development by providing consistency, speed and scale ... how many months left in the year